Publications

2006-2004

1. Arnold P.D., Sicard T., Burroughs E., Richter M.A. and Kennedy J.L. Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder. Archives of General Psychiatry, 2006, 63(7), pp.769-776
2. Hu X.Z., Lipsky R.H., Zhu G., Akhtar L.A., Taubman J., Greenberg B.D., Xu K., Arnold P.D., Richter M.A., Kennedy J.L. and Murphy D.L. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. The American Journal of Human Genetics, 78(5), 2006, pp.815-826
3. Zai G., Arnold P.D., Burroughs E., Richter M.A. and Kennedy J.L. Tumour necrosis-alpha gene is not associated with obsessive-compulsive disorder. Psychiatric Genetics, 16(1), 2006, pp. 43-45
4. Zai G., Arnold P.D., Strauss J., King N., Burroughs E., Richter M.A. and Kennedy J.L. No association between Brain-Derived Neurotrophic Factor (BDNF) gene and obsessive-compulsive disorder. Psychiatric Genetics, 15(4), 2005, p. 235 
5. Arnold P.D., Ickowicz I., Chen S. and Schachar R.J. Attention-deficit hyperactivity disorder with and without obsessive- compulsive behaviours: clinical characteristics, cognitive assessment, and risk factors.  Canadian Journal of Psychiatry, 50(1), 2005, pp. 59-66
6. Zai G., Arnold P.D, Burroughs E., Barr C.L., Richter M.A. and Kennedy J.L. Evidence for the gamma‐amino‐butyric acid type B receptor 1 (GABBR1) gene as a susceptibility factor in obsessive‐compulsive disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 134(1), 2005, pp.25-29
7. Arnold P.D., Rosenberg D.R., Mundo E., Tharmalingam S., Kennedy J.L. and Richter M.A. Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: a preliminary study. Psychopharmacology, 174(4), 2004, pp.530-538
8. Arnold P.D., Zai G. and Richter M.A. Genetics of anxiety disorders. Current Psychiatry Reports, 6(4), 2004,  pp.243-25
9. Shinkai T., De Luca V., Zai G., Shaikh S., Matsumoto C., Arnold P.D., Hwang R., King N., Trakalo J., Potapova N. and Wong G. No association between the Pro197Leu polymorphism in the glutathione peroxidase (GPX1) gene and schizophrenia. Psychiatric genetics, 14(3), 2004, pp.177-180
10. Zai G., Bezchlibnyk Y.B., Richter M.A., Arnold P., Burroughs E., Barr C.L. and Kennedy J.L. Myelin oligodendrocyte glycoprotein (MOG) gene is associated with obsessive‐compulsive disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 129(1), 2004, pp.64-68​